Testa JS - Search Results

1

Role of T-cell epitope-based vaccine in prophylactic and therapeutic applications.

Testa JS, Philip R. Testa JS, et al. Future Virol. 2012 Nov 1;7(11):1077-1088. doi: 10.2217/fvl.12.108. Future Virol. 2012. PMID: 23630544 Free PMC article.

2

MHC Class I Presented T Cell Epitopes as Potential Antigens for Therapeutic Vaccine against HBV Chronic Infection.

Comber JD, Karabudak A, Shetty V, Testa JS, Huang X, Philip R. Comber JD, et al. Among authors: testa js. Hepat Res Treat. 2014;2014:860562. doi: 10.1155/2014/860562. Epub 2014 May 26. Hepat Res Treat. 2014. PMID: 24971174 Free PMC article.

3

Conserved MHC class I-presented dengue virus epitopes identified by immunoproteomics analysis are targets for cross-serotype reactive T-cell response.

Testa JS, Shetty V, Sinnathamby G, Nickens Z, Hafner J, Kamal S, Zhang X, Jett M, Philip R. Testa JS, et al. J Infect Dis. 2012 Feb 15;205(4):647-55. doi: 10.1093/infdis/jir814. Epub 2012 Jan 13. J Infect Dis. 2012. PMID: 22246683 Free PMC article.

4

MHC class I-presented T cell epitopes identified by immunoproteomics analysis are targets for a cross reactive influenza-specific T cell response.

Testa JS, Shetty V, Hafner J, Nickens Z, Kamal S, Sinnathamby G, Philip R. Testa JS, et al. PLoS One. 2012;7(11):e48484. doi: 10.1371/journal.pone.0048484. Epub 2012 Nov 7. PLoS One. 2012. PMID: 23144892 Free PMC article.

5

Quantitative immunoproteomics analysis reveals novel MHC class I presented peptides in cisplatin-resistant ovarian cancer cells.

Shetty V, Nickens Z, Testa J, Hafner J, Sinnathamby G, Philip R. Shetty V, et al. J Proteomics. 2012 Jun 18;75(11):3270-90. doi: 10.1016/j.jprot.2012.03.044. Epub 2012 Apr 3. J Proteomics. 2012. PMID: 22504797

6

A ubiquitin independent degradation pathway utilized by a hepatitis B virus envelope protein to limit antigen presentation.

Liu Y, Testa JS, Philip R, Block TM, Mehta AS. Liu Y, et al. Among authors: testa js. PLoS One. 2011;6(9):e24477. doi: 10.1371/journal.pone.0024477. Epub 2011 Sep 28. PLoS One. 2011. PMID: 21969857 Free PMC article.

7

Exosome-driven antigen transfer for MHC class II presentation facilitated by the receptor binding activity of influenza hemagglutinin.

Testa JS, Apcher GS, Comber JD, Eisenlohr LC. Testa JS, et al. J Immunol. 2010 Dec 1;185(11):6608-16. doi: 10.4049/jimmunol.1001768. Epub 2010 Nov 3. J Immunol. 2010. PMID: 21048109 Free PMC article.

8

Inhibition of oncogene-induced inflammatory chemokines using a farnesyltransferase inhibitor.

Degeorge KC, Degeorge BR Jr, Testa JS, Rothstein JL. Degeorge KC, et al. Among authors: testa js. J Inflamm (Lond). 2008 Feb 27;5:3. doi: 10.1186/1476-9255-5-3. J Inflamm (Lond). 2008. PMID: 18304343 Free PMC article.

9

In vitro hypoxia-conditioned colon cancer cell lines derived from HCT116 and HT29 exhibit altered apoptosis susceptibility and a more angiogenic profile in vivo.

Yao K, Gietema JA, Shida S, Selvakumaran M, Fonrose X, Haas NB, Testa J, O'Dwyer PJ. Yao K, et al. Br J Cancer. 2005 Dec 12;93(12):1356-63. doi: 10.1038/sj.bjc.6602864. Br J Cancer. 2005. PMID: 16333244 Free PMC article.

10

A response from Thomson Reuters.

Testa J. Testa J. Epidemiology. 2009 May;20(3):319-20. doi: 10.1097/EDE.0b013e3181a1163f. Epidemiology. 2009. PMID: 19363352 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters